457 related articles for article (PubMed ID: 18300111)
1. Influence of cytokine gene polymorphisms on IgA nephropathy.
Bantis C; Heering P; Aker S; Kuhr N; Grabensee B; Ivens K
Ren Fail; 2008; 30(2):135-40. PubMed ID: 18300111
[TBL] [Abstract][Full Text] [Related]
2. Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation.
Breulmann B; Bantis C; Siekierka M; Blume C; Aker S; Kuhr N; Grabensee B; Ivens K
Clin Transplant; 2007; 21(5):615-21. PubMed ID: 17845635
[TBL] [Abstract][Full Text] [Related]
3. Influence of cytokine gene polymorphisms on focal segmental glomerulosclerosis.
Bantis C; Heering PJ; Luther Y; Aker S; Kuhr N; Grabensee B; Ivens K
Am J Nephrol; 2004; 24(4):427-31. PubMed ID: 15308875
[TBL] [Abstract][Full Text] [Related]
4. Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients.
Brezzi B; Del Prete D; Lupo A; Magistroni R; Gomez-Lira M; Bernich P; Anglani F; Mezzabotta F; Turco A; Furci L; Ceol M; Antonucci F; Abaterusso C; Bonfante L; D'Angelo A; Albertazzi A; Gambaro G
J Nephrol; 2009; 22(6):747-59. PubMed ID: 19967654
[TBL] [Abstract][Full Text] [Related]
5. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
6. Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathy.
Carturan S; Roccatello D; Menegatti E; Di Simone D; Davit A; Piazza A; Sena LM; Matullo G
J Nephrol; 2004; 17(6):786-93. PubMed ID: 15593052
[TBL] [Abstract][Full Text] [Related]
7. Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients.
Masutani K; Miyake K; Nakashima H; Hirano T; Kubo M; Hirakawa M; Tsuruya K; Fukuda K; Kanai H; Otsuka T; Hirakata H; Iida M
Am J Kidney Dis; 2003 Feb; 41(2):371-9. PubMed ID: 12552499
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis.
Bantis C; Heering PJ; Aker S; Siekierka M; Kuhr N; Grabensee B; Ivens K
Am J Nephrol; 2006; 26(1):12-5. PubMed ID: 16391465
[TBL] [Abstract][Full Text] [Related]
9. [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients].
Iñigo P; Lario S; Campistol JM; Bescós M; Campos B; Oppenheimer F
Nefrologia; 2003; 23(4):312-20. PubMed ID: 14558330
[TBL] [Abstract][Full Text] [Related]
10. Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy.
Bantis C; Heering PJ; Aker S; Schwandt C; Grabensee B; Ivens K
J Nephrol; 2008; 21(6):941-6. PubMed ID: 19034880
[TBL] [Abstract][Full Text] [Related]
11. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
12. Cytokine gene polymorphism in kidney transplantation--impact of TGF-beta 1, TNF-alpha and IL-6 on graft outcome.
Nikolova PN; Ivanova MI; Mihailova SM; Myhailova AP; Baltadjieva DN; Simeonov PL; Paskalev EK; Naumova EJ
Transpl Immunol; 2008 Feb; 18(4):344-8. PubMed ID: 18158121
[TBL] [Abstract][Full Text] [Related]
13. The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.
Eliopoulos DG; Mavroudi I; Pontikoglou C; Ximeri M; Stavroulaki E; Pyrovolaki K; Velegraki M; Spanoudakis M; Goulielmos G; Papadaki HA
Eur J Haematol; 2009 Dec; 83(6):535-40. PubMed ID: 19614955
[TBL] [Abstract][Full Text] [Related]
14. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with chronic allograft nephropathy and graft survival in Korean renal transplant recipients.
Cho JH; Huh S; Kwon TG; Choi JY; Hur IK; Lee EY; Park SH; Kim YL; Kim CD
Transplant Proc; 2008 Sep; 40(7):2355-60. PubMed ID: 18790234
[TBL] [Abstract][Full Text] [Related]
15. Relevance of transforming growth factor-beta1, interleukin-8, and tumor necrosis factor-alpha polymorphisms in patients with chronic pancreatitis.
Farkas G; Hofner P; Balog A; Takács T; Szabolcs A; Farkas G; Mándi Y
Eur Cytokine Netw; 2007 Mar; 18(1):31-7. PubMed ID: 17400536
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy.
Sato F; Narita I; Goto S; Kondo D; Saito N; Ajiro J; Saga D; Ogawa A; Kadomura M; Akiyama F; Kaneko Y; Ueno M; Sakatsume M; Gejyo F
Tissue Antigens; 2004 Jul; 64(1):35-42. PubMed ID: 15191521
[TBL] [Abstract][Full Text] [Related]
17. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.
Migita K; Miyazoe S; Maeda Y; Daikoku M; Abiru S; Ueki T; Yano K; Nagaoka S; Matsumoto T; Nakao K; Hamasaki K; Yatsuhashi H; Ishibashi H; Eguchi K
J Hepatol; 2005 Apr; 42(4):505-10. PubMed ID: 15763337
[TBL] [Abstract][Full Text] [Related]
18. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients.
Babel N; Vergopoulos A; Trappe RU; Oertel S; Hammer MH; Karaivanov S; Schneider N; Riess H; Papp-Vary M; Neuhaus R; Gondek LP; Volk HD; Reinke P
Transplantation; 2007 Aug; 84(3):387-91. PubMed ID: 17700165
[TBL] [Abstract][Full Text] [Related]
19. Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients.
Altun B; Yilmaz R; Kahraman S; Gençtoy G; Arici M; Onalan O; Oto A; Hayran M; Bakkaloğlu M; Yasavul U; Turgan C
Transpl Int; 2005 Jun; 18(6):681-9. PubMed ID: 15910294
[TBL] [Abstract][Full Text] [Related]
20. The involvement of IL-10, IL-6, IFN-gamma, TNF-alpha and TGF-beta gene polymorphisms among Turkish lung cancer patients.
Colakogullari M; Ulukaya E; Yilmaztepe Oral A; Aymak F; Basturk B; Ursavas A; Oral HB
Cell Biochem Funct; 2008 Apr; 26(3):283-90. PubMed ID: 17654453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
